...
首页> 外文期刊>Journal of ocular pharmacology and therapeutics: The official journal of the Association for Ocular Pharmacology and Therapeutics >Comparison of 0.1%, 0.18%, and 0.3% Hyaluronic Acid Eye Drops in the Treatment of Experimental Dry Eye
【24h】

Comparison of 0.1%, 0.18%, and 0.3% Hyaluronic Acid Eye Drops in the Treatment of Experimental Dry Eye

机译:在实验干眼症治疗中比较0.1%,0.18%和0.3%透明质酸滴眼液

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To compare the efficacy of 0.1%, 0.18%, and 0.3% hyaluronic acid (HA) artificial tear in the treatment of experimental dry eye (EDE). Methods: EDE was established in female C57BL/6 mice through an air draft and subcutaneous scopolamine injection. The mice were divided into 5 groups according to topical treatment regimens (n=5 each): EDE control, balanced salt solution (BSS), preservative-free 0.1% HA, 0.18% HA, and 0.3% HA. The tear film break-up time (TBUT) and corneal fluorescein staining scores were measured 5, 10, 14, 21, and 28 days after treatment. The corneal smoothness scores were measured. In addition, periodic acid-Schiff (PAS) and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining were performed. Results: The values for TBUT and corneal fluorescein staining showed greater improvements in all the HA groups (P0.05) than in the EDE and BSS groups after 10 days of treatment. Mice treated with 0.3% HA showed a more significant improvement in all clinical parameters than did those in the EDE control, BSS, 0.1% HA, and 0.18% HA groups (all P0.05) after 28 days of treatment. The goblet cell counts were higher in the 0.3% and 0.18% HA groups than in the 0.1% HA group. The number of TUNEL-positive cells was the lowest in the 0.3% HA group. Conclusions: In EDE, 0.3% HA artificial tears are more effective than the 0.1% and 0.18% HA in improving tear film instability and ocular surface staining and irregularity, in increasing the number of conjunctival goblet cells, and in decreasing corneal epithelial apoptosis.
机译:目的:比较0.1%,0.18%和0.3%透明质酸(HA)人造撕裂治疗实验性皮眼(EDE)的疗效。方法:通过空气径和皮下汽油胺注射在雌性C57BL / 6小鼠中建立EDE。根据局部治疗方案(每个N = 5)分为5组小鼠:EDE控制,平衡盐溶液(BSS),无防腐剂0.1%HA,0.18%HA和0.3%HA。测定治疗后5,10,14,21和28天的泪膜分解时间(TBUT)和角膜荧光蛋白染色分数。测量角膜平滑度分数。另外,进行核酸 - 席夫(PAS)和末端脱氧核苷酸转移酶DUTP缺口末端标记(TUNEL)染色。结果:TBUT和角膜荧光素染色的值显示出在处理10天后的EDE和BSS组中的所有HA基团(P <0.05)的更大改善。用0.3%HA处理的小鼠在所有临床参数中显示出比EDE对照,BSS,0.1%HA和0.18%HA组(所有P <0.05)治疗后的临床参数更大的改善。在0.3%和0.18%的HA组中比在0.1%HA组中较高。 TUNEL阳性细胞的数量是0.3%HA组中最低的。结论:在EDE中,在提高泪膜不稳定和眼表面染色和不规则中,0.3%HA人工泪液比0.1%和0.18%HA更有效,在增加结膜脚卵细胞的数量,以及降低角膜上皮细胞凋亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号